Quoin Pharmaceuticals Ltd. (QNRX) stock
QNRXNasdaqPharmaceutical Preparations
$3.56+0.20 (+5.95%)
Close on Nov 18, 2026Market cap $7.15MP/E –Yield –
Quoin Pharmaceuticals r&d expenses
Research and development expenses are spending on new products and technology.
Quoin Pharmaceuticals's R&D Expenses for the twelve months ending Jun 30, 2026 was $12.44M, up 89.8% year over year. For fiscal 2025 it was $9.80M, up 172.1% from the year before. The highest annual figure on record is $9.80M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.80M | +172.1% |
| FY2024 | Dec 31, 2024 | $3.60M | +8.9% |
| FY2023 | Dec 31, 2023 | $3.31M | +23.8% |
| FY2022 | Dec 31, 2022 | $2.67M | +71.0% |
| FY2021 | Dec 31, 2021 | $1.56M | +540.1% |
| FY2020 | Dec 31, 2020 | $244.16K | +434.8% |
| FY2019 | Dec 31, 2019 | $45.65K | -98.6% |
| FY2017 | Dec 31, 2017 | $3.32M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.63M | +76.9% |
| Q1 FY2026 | Mar 31, 2026 | $3.43M | +44.6% |
| Q4 FY2025 | Dec 31, 2025 | $3.10M | +194.9% |
| Q3 FY2025 | Sep 30, 2025 | $2.28M | +111.3% |
| Q2 FY2025 | Jun 30, 2025 | $2.05M | +249.0% |
| Q1 FY2025 | Mar 31, 2025 | $2.37M | +168.2% |
| Q4 FY2024 | Dec 31, 2024 | $1.05M | +26.2% |
| Q3 FY2024 | Sep 30, 2024 | $1.08M | +42.3% |
| Q2 FY2024 | Jun 30, 2024 | $587.50K | -6.0% |
| Q1 FY2024 | Mar 31, 2024 | $885.30K | -18.9% |
| Q4 FY2023 | Dec 31, 2023 | $832.39K | +35.8% |
| Q3 FY2023 | Sep 30, 2023 | $758.76K | +1.8% |
| Q2 FY2023 | Jun 30, 2023 | $625.10K | -14.0% |
| Q1 FY2023 | Mar 31, 2023 | $1.09M | +85.8% |
| Q4 FY2022 | Dec 31, 2022 | $613.07K | -39.1% |
| Q3 FY2022 | Sep 30, 2022 | $745.51K | +186.7% |
| Q2 FY2022 | Jun 30, 2022 | $726.69K | +203.7% |
| Q1 FY2022 | Mar 31, 2022 | $587.57K | – |
| Q4 FY2021 | Dec 31, 2021 | $1.01M | – |
| Q3 FY2021 | Sep 30, 2021 | $260.00K | – |
| Q2 FY2021 | Jun 30, 2021 | $239.28K | – |
See a number that looks wrong?